Literature DB >> 17330684

Clostridium difficile: association with thrombocytosis and leukocytosis.

Werner C Albrich1, David Rimland.   

Abstract

BACKGROUND: Apart from leukocytosis, few laboratory markers suggestive of Clostridium difficile infections have been described.
METHODS: We retrospectively analyzed the association between thrombocytosis, leukocytosis and C. difficile infections at the Atlanta Veterans Affairs Medical Center.
RESULTS: Of 162 patients with C. difficile infection, 36 (22%) had thrombocytosis, and 97 (60%) had leukocytosis. C difficile toxin A ELISA was performed in 46/695 (6.6%) patients with thrombocytosis and was positive in 18 (39.1%). Leukocytosis was present in 16/18 (89%) of patients with positive C. difficile toxin A ELISA and thrombocytosis, but also in 21/28 (75%) of patients with negative C. difficile toxin A ELISA and thrombocytosis. Among patients with marked leukocytosis, C. difficile toxin A was more frequently detected in those with concomitant thrombocytosis (P = 0.07).
CONCLUSIONS: The presence of thrombocytosis may be helpful to improve the pretest probability for C difficile infections.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17330684     DOI: 10.1097/SMJ.0b013e31802ea5ac

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  2 in total

1.  Thrombocytopenia in hospitalized patients with severe clostridium difficile infection.

Authors:  Eric M Fountain; Maggie C Moses; Lawrence P Park; Christopher W Woods; Gowthami M Arepally
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

2.  Etiology of thrombocytosis in a general medicine population: analysis of 801 cases with emphasis on infectious causes.

Authors:  Stacey R Rose; Nancy J Petersen; Tracie J Gardner; Richard J Hamill; Barbara W Trautner
Journal:  J Clin Med Res       Date:  2012-11-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.